About ExRNA
Manuscript Submission
AME Editing Service
Reprint & Permission
Advertising
Contact us
-
General editorial enquiries:
Email: exrna@amepc.org -
Copyright related contact:
Email: permissions@amegroups.com -
Commercial Sales contact (Reprints, advertising, etc.):
Email: sales@amegroups.com
Original Article
ExRNA
2023;
5:
4
(27 September 2023)
Review Article
ExRNA
2023;
5:
3
(22 September 2023)
Review Article
ExRNA
2023;
5:
2
(31 July 2023)
Review Article
ExRNA
2023;
5:
1
(30 January 2023)
Letter to the Editor
ExRNA
2022;
4:
27
(30 December 2022)
Review Article
ExRNA
2022;
4:
26
(30 December 2022)
Editorial Commentary
ExRNA
2022;
4:
25
(30 November 2022)
Review Article
ExRNA
2022;
4:
24
(30 November 2022)
Editorial Commentary
ExRNA
2022;
4:
23
(31 October 2022)
Review Article
ExRNA
2022;
4:
22
(31 October 2022)
Editorial Commentary
ExRNA
2022;
4:
21
(30 September 2022)
Original Article
ExRNA
2022;
4:
20
(30 September 2022)
Letter to the Editor
ExRNA
2022;
4:
19
(30 August 2022)
Review Article
ExRNA
2022;
4:
18
(30 August 2022)
Editorial Commentary
ExRNA
2022;
4:
17
(30 July 2022)
Letter to the Editor
ExRNA
2022;
4:
15
(30 June 2022)
Review Article
ExRNA
2022;
4:
14
(30 June 2022)
Editorial Commentary
ExRNA
2022;
4:
13
(31 May 2022)
Review Article
ExRNA
2022;
4:
12
(31 May 2022)
Currently no content available!